Rossini F
Haematology Unit, New Hospital S. Gerardo, Monza, Italy.
Support Care Cancer. 1996 Jan;4(1):46-50. doi: 10.1007/BF01769875.
The goal of work was to evaluate epidemiological features and prognostic factors of infections in elderly patients affected by haematological neoplasms. From 1 May 1989 to 30 April 1994 we observed 765 infectious episodes in 416 patients: 554 in patients younger than 65, 211 in patients aged over 65. No difference in rate of combined- or single-agent antibiotic therapy was present, nor in the rate of patients receiving growth factors. The outcome has been classified as positive, death from infections or death from causes other than infection (NID). When all deaths are considered, younger patients had a lower rate of death (120/554, 22%) than the elderly (59/211, 28%) P = 0.069 (Fisher's exact test). When NID are excluded 77/511 (15%) younger patients and 34/186 (18%) elderly patients died P = 0.34. A significantly higher rate of younger patients had an absolute neutrophil count (ANC) lower than 500/mm3 at the onset: younger patients 322/554 (58%), the elderly 79/211 (38%) P < 0.00001. When only neutropenic (ANC < 500/mm3) patients are considered, the difference in outcome between the two groups is more evident: positive outcome was achieved by 251/322 younger (78%) and by 49/79 elderly patients (62%) P = 0.004; when NID were excluded, positive outcome was achieved by 251/306 younger (82%) and by 49/68 elderly patients (72%) P = 0.066. Taking into account a higher rate of NID, it is possible to achieve an outcome for infection in the elderly that is not significantly different from that in younger patients, when less severe neutropenia is induced. However, among neutropenic patients, the prognosis for infections become poorer in elderly patients. This must be evaluated when aggressive chemotherapy for these patients is being designed.
该研究的目的是评估血液系统肿瘤老年患者感染的流行病学特征和预后因素。1989年5月1日至1994年4月30日,我们观察了416例患者中的765次感染发作:65岁以下患者554次,65岁以上患者211次。联合或单药抗生素治疗率以及接受生长因子治疗的患者比例均无差异。结局分为阳性、死于感染或死于感染以外的原因(非感染性死亡)。当考虑所有死亡病例时,年轻患者的死亡率(120/554,22%)低于老年患者(59/211,28%),P = 0.069(Fisher精确检验)。排除非感染性死亡后,77/511(15%)的年轻患者和34/186(18%)的老年患者死亡,P = 0.34。年轻患者发病时绝对中性粒细胞计数(ANC)低于500/mm³的比例显著更高:年轻患者为322/554(58%),老年患者为79/211(38%),P < 0.